[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f2DVzmBNPmCEpX2wPjajhqaGX2CxD143Uk9927H_r07E":3},{"_id":4,"category":5,"content":9,"date":10,"heroImage":9,"newsPageBuilder":11,"seo":9,"slug":59,"title":60},"c5de3dfb-4052-4419-8e80-c64bfe8d9a33",{"_id":6,"slug":7,"title":8},"c098646c-9061-4278-96a9-6a3e9a140b5a","events","Events",null,"2022-01-11T00:00:00.000Z",[12],{"_key":13,"_type":14,"content":15},"nc20","newsContent",[16,27,35,43,51],{"_key":17,"_type":18,"children":19,"markDefs":25,"style":26},"b20p1","block",[20],{"_key":21,"_type":22,"marks":23,"text":24},"s20p1","span",[],"Peripheral nerve injuries continue to challenge orthopedic surgeons due to their significant impact on patient quality of life. KLISBio is addressing this clinical need with SILKBridge, described as a first-to-market solution for peripheral nerve repair. The company presented this innovation at the American Association for Hand Surgeons Annual Meeting held January 12-15, 2022.",[],"normal",{"_key":28,"_type":18,"children":29,"markDefs":34,"style":26},"b20p2",[30],{"_key":31,"_type":22,"marks":32,"text":33},"s20p2",[],"SILKBridge is a tissue-engineered graft composed of pure silk fibroin. The technology combines the mechanical strength of native silk fibers with the biological properties of electrospun silk. It is designed to support peripheral nerve regeneration across damaged areas and was anticipated to reach clinical use in 2023.",[],{"_key":36,"_type":18,"children":37,"markDefs":42,"style":26},"b20p3",[38],{"_key":39,"_type":22,"marks":40,"text":41},"s20p3",[],"CEO Gabriele Grecchi expressed enthusiasm about the product's potential, stating it represents the company's commitment to disrupting the restorative surgical market. He emphasized the company's broader mission to challenge the status quo in regenerative medicine by leveraging silk as a powerful and biocompatible scaffold material.",[],{"_key":44,"_type":18,"children":45,"markDefs":50,"style":26},"b20p4",[46],{"_key":47,"_type":22,"marks":48,"text":49},"s20p4",[],"KLISBio focuses on tissue healing and regeneration using a silk-based technology platform. The company targets multiple clinical areas including peripheral nerve injuries, vascular diseases, bone defects, and tendon repairs. The Milan-based company holds patents in silk fibroin combinations, composites, and nanofiber structures.",[],{"_key":52,"_type":18,"children":53,"markDefs":58,"style":26},"b20p5",[54],{"_key":55,"_type":22,"marks":56,"text":57},"s20p5",[],"Beyond SILKBridge, KLISBio has vascular grafts, bone substitutes, and rotator cuff repair solutions in development.",[],"klisbio-aahs-2022","KLISBio to feature engineered silk innovation at AAHS 2022"]